1. Home
  2. NABL vs AMPH Comparison

NABL vs AMPH Comparison

Compare NABL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$3.40

Market Cap

945.6M

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$16.94

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NABL
AMPH
Founded
2000
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
945.6M
971.8M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
NABL
AMPH
Price
$3.40
$16.94
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
$8.31
$28.38
AVG Volume (30 Days)
1.0M
544.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$511,430,000.00
$719,887,000.00
Revenue This Year
$11.04
$6.90
Revenue Next Year
$8.53
$4.64
P/E Ratio
N/A
$124.00
Revenue Growth
9.71
N/A
52 Week Low
$3.32
$17.03
52 Week High
$9.04
$31.26

Technical Indicators

Market Signals
Indicator
NABL
AMPH
Relative Strength Index (RSI) 25.47 31.72
Support Level N/A N/A
Resistance Level $5.22 $24.16
Average True Range (ATR) 0.33 0.86
MACD -0.23 -0.62
Stochastic Oscillator 7.34 2.44

Price Performance

Historical Comparison
NABL
AMPH

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: